Nov 5, 4:19 PM ET
HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed on November 5, 2026 a public offering of $6.5 billion of senior unsecured notes in seven series maturing from 2028 to 2056, fully guaranteed by HCA Healthcare. The filing does not state how the proceeds will be used, but the offering adds $6.5 billion of debt obligations for the company.
- Seven series totaling $6.5 billion; the largest is $1.5 billion of 6.000% senior notes due November 15, 2036.
- Fixed-rate coupons range from 5.200% to 6.500%, and $300 million of floating-rate notes mature November 3, 2028.
- Underwriting agreement dated November 2, 2026 with Mizuho Securities USA LLC, Barclays Capital Inc., BofA Securities, Inc. and Wells Fargo Securities, LLC as representatives.
- Holders can require repurchase at 101% of principal only upon both a qualifying ratings downgrade and a change of control.
Read the filing on SEC.gov ↗
Nov 2, 5:04 PM ET
HCA Healthcare's wholly owned subsidiary, HCA Inc., proposed a public offering of senior unsecured notes on November 2, 2026, with terms to depend on market conditions. The subsidiary also gave notice it will redeem all $1.200 billion of its 4.500% senior notes due February 2027 on December 2, 2026, conditioned on receiving offering proceeds, which may also repay commercial paper and credit facility borrowings.
- Proposed offering of senior unsecured notes by HCA Inc.; maturity, interest rate and principal amount not yet set
- Notice given November 2, 2026 to redeem all $1.200 billion of 4.500% senior notes due February 2027 on December 2, 2026
- Net proceeds may be used for general corporate purposes, including the redemption, repaying up to $8.000 billion commercial paper program borrowings, and repaying senior unsecured credit facility borrowings
Read the filing on SEC.gov ↗
Oct 27, 7:17 AM ET
HCA Healthcare reported third quarter 2026 revenue of $19.849 billion and net income of $1.579 billion, alongside an updated full-year operating forecast in the upper half of its previously issued ranges. The company experienced an unfavorable payer mix shift due to increased uninsured volume, which negatively impacted pre-tax income by approximately $400 million.
- Revenues increased 3.6 percent to $19.849 billion in the third quarter of 2026.
- Net income attributable to HCA Healthcare, Inc. declined 3.9 percent to $1.579 billion.
- The Board of Directors declared a quarterly cash dividend of $0.78 per share payable on December 29, 2026.
- The company repurchased 7.230 million shares of its common stock at a cost of $2.970 billion during the third quarter.
Read the filing on SEC.gov ↗
Jul 24, 7:45 AM ET
HCA Healthcare reported second-quarter 2026 revenue of $20.230 billion, up 8.7%, and diluted EPS of $7.62, up 11.6%. The company lowered its 2026 guidance for net income, EPS and Adjusted EBITDA, citing a payer mix shift from uninsured volume tied to health insurance exchanges, which it estimated reduced second-quarter income before income taxes by approximately $400 million.
- Q2 2026 revenue was $20.230 billion, up 8.7% from $18.605 billion; diluted EPS was $7.62 versus $6.83 a year earlier.
- Revised 2026 diluted EPS guidance is $28.70 to $30.50, down from $29.10 to $31.50; net income guidance is $6.300 to $6.700 billion, down from $6.495 to $7.035 billion.
- The exchange-related payer mix shift had an unfavorable impact of approximately $400 million on Q2 income before income taxes, partly offset by about $400 million of incremental Medicaid Supplemental Payment Program benefit.
- The Board declared a quarterly cash dividend of $0.78 per share, payable September 30, 2026 to holders of record on September 16, 2026.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.